» Articles » PMID: 24529209

Posterior Fossa and Spinal Gangliogliomas Form Two Distinct Clinicopathologic and Molecular Subgroups

Overview
Publisher Biomed Central
Specialty Neurology
Date 2014 Feb 18
PMID 24529209
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Gangliogliomas are low-grade glioneuronal tumors of the central nervous system and the commonest cause of chronic intractable epilepsy. Most gangliogliomas (>70%) arise in the temporal lobe, and infratentorial tumors account for less than 10%. Posterior fossa gangliogliomas can have the features of a classic supratentorial tumor or a pilocytic astrocytoma with focal gangliocytic differentiation, and this observation led to the hypothesis tested in this study - gangliogliomas of the posterior fossa and spinal cord consist of two morphologic types that can be distinguished by specific genetic alterations.

Results: Histological review of 27 pediatric gangliogliomas from the posterior fossa and spinal cord indicated that they could be readily placed into two groups: classic gangliogliomas (group I; n = 16) and tumors that appeared largely as a pilocytic astrocytoma, but with foci of gangliocytic differentiation (group II; n = 11). Detailed radiological review, which was blind to morphologic assignment, identified a triad of features, hemorrhage, midline location, and the presence of cysts or necrosis, that distinguished the two morphological groups with a sensitivity of 91% and specificity of 100%. Molecular genetic analysis revealed BRAF duplication and a KIAA1549-BRAF fusion gene in 82% of group II tumors, but in none of the group I tumors, and a BRAF:p.V600E mutation in 43% of group I tumors, but in none of the group II tumors.

Conclusions: Our study provides support for a classification that would divide infratentorial gangliogliomas into two categories, (classic) gangliogliomas and pilocytic astrocytomas with gangliocytic differentiation, which have distinct morphological, radiological, and molecular characteristics.

Citing Articles

Ganglioglioma in mature cystic teratoma of the ovary: Case report and review of the literature.

Zhao C, Lin W, Hei M, Liu W, Hui D, Guan J Gynecol Oncol Rep. 2025; 58:101700.

PMID: 40041738 PMC: 11876757. DOI: 10.1016/j.gore.2025.101700.


Three Years of Progression-free after Biopsy of BRAF V600E-negative Ganglioglioma in the Adult Brainstem: A Case Report and the Literature Review.

Ishikura T, Hirono S, Ota M, Yokoyama D, Kobayashi M, Matsutani T NMC Case Rep J. 2025; 11():427-433.

PMID: 39850766 PMC: 11756899. DOI: 10.2176/jns-nmc.2024-0189.


Unraveling morphology, methylation profiling, and diagnostic challenges in BRAF-Mutant pediatric glial and glioneuronal tumors.

Alturkustani M Neurosciences (Riyadh). 2024; 29(3):168-176.

PMID: 38981632 PMC: 11305341. DOI: 10.17712/nsj.2024.3.20230108.


Classification of Pediatric Gangliogliomas Based on the Histological Infiltration.

Alturkustani M Curr Oncol. 2022; 29(10):6764-6775.

PMID: 36290809 PMC: 9600553. DOI: 10.3390/curroncol29100532.


Ganglioglioma of the cervicothoracic spinal cord in a patient with neurofibromatosis type 1: A case report.

Cruz T, Ferreira-Pinto P, Brito A, Ururahy L, Sanchez J, Nigri F Surg Neurol Int. 2021; 12:313.

PMID: 34345454 PMC: 8326088. DOI: 10.25259/SNI_192_2021.


References
1.
Pfister S, Janzarik W, Remke M, Ernst A, Werft W, Becker N . BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest. 2008; 118(5):1739-49. PMC: 2289793. DOI: 10.1172/JCI33656. View

2.
Gessi M, Lambert S, Lauriola L, Waha A, Collins V, Pietsch T . Absence of KIAA1549-BRAF fusion in rosette-forming glioneuronal tumors of the fourth ventricle (RGNT). J Neurooncol. 2012; 110(1):21-5. DOI: 10.1007/s11060-012-0940-2. View

3.
Zhang J, Wu G, Miller C, Tatevossian R, Dalton J, Tang B . Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet. 2013; 45(6):602-12. PMC: 3727232. DOI: 10.1038/ng.2611. View

4.
Luyken C, Blumcke I, Fimmers R, Urbach H, Wiestler O, Schramm J . Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer. 2004; 101(1):146-55. DOI: 10.1002/cncr.20332. View

5.
Baussard B, Di Rocco F, Garnett M, Boddaert N, Lellouch-Tubiana A, Grill J . Pediatric infratentorial gangliogliomas: a retrospective series. J Neurosurg. 2007; 107(4 Suppl):286-91. DOI: 10.3171/PED-07/10/286. View